Figures & data
short-legendFigure 1 
short-legendFigure 2 
short-legendFigure 3 
Emerging Microbes & Infections
Volume 6, 2017 - Issue 1
Related Research Data
Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains.
Source:
Elsevier BV
Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia.
Source:
Informa UK Limited
Predominance of rotavirus genotype G6P[11] in diarrhoeic lambs.
Source:
Elsevier BV
Prevalence and Diversity of Rotavirus Strains in Children with Acute Diarrhea from Rural Communities in the Limpopo Province, South Africa, from 1998 to 2000
Source:
Oxford University Press (OUP)
Rotarix™ (RIX4414): an oral human rotavirus vaccine
Source:
Informa UK Limited
Initial Interaction of Rotavirus Strains with N-Acetylneuraminic (Sialic) Acid Residues on the Cell Surface Correlates with VP4 Genotype, Not Species of Origin
Source:
American Society for Microbiology
The Pentavalent Rotavirus Vaccine: Discovery to Licensure and Beyond
Source:
Oxford University Press (OUP)
Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates
Source:
Elsevier BV
Rotavirus Strains Bearing Genotype G9 or P[9] Recovered from Brazilian Children with Diarrhea from 1997 to 1999
Source:
American Society for Microbiology
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus
Source:
Nature Publishing Group
Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.
Source:
Springer Science and Business Media LLC
Development of RotaTeq, a rotavirus vaccine
Source:
Wiley
Economic Evaluation of the National Immunization Program of Rotavirus Vaccination for Children in Korea
Source:
SAGE Publications
Epidemiology of Rotavirus Gastroenteritis among Children <5 Years of Age in Morocco during 1 Year of Sentinel Hospital Surveillance, June 2006–May 2007
Source:
Oxford University Press (OUP)
Norovirus P Particle as a Platform for Antigen Presentation
Source:
Elsevier BV
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
Source:
Oxford University Press (OUP)
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens
Source:
American Society for Microbiology
Rotavirus and Severe Childhood Diarrhea
Source:
Centers for Disease Control and Prevention (CDC)
Rotaviral immunity in gnotobiotic calves : heterologous resistance to human virus induced by bovine virus.
Source:
American Association for the Advancement of Science (AAAS)
Association between Norovirus and Rotavirus Infection and Histo-Blood Group Antigen Types in Vietnamese Children
Source:
American Society for Microbiology
Position of human blood group O(H) and phenotype-determining enzymes in growth and infectious disease
Source:
Wiley
Histo-blood group antigens: a common niche for norovirus and rotavirus.
Source:
Cambridge University Press (CUP)
Noroviral P particle: structure, function and applications in virus-host interaction.
Source:
Elsevier BV
Subviral particle as vaccine and vaccine platform
Source:
Elsevier BV
[Expression of ABH and Lewis antigens in chronic gastritis and pre-neoplasic alterations in gastric mucosa].
Source:
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE.
Molecular epidemiology of group A rotaviruses in water sources and selected raw vegetables in southern Africa.
Source:
American Society for Microbiology
Surveillance of Rotavirus Strains in Rio de Janeiro, Brazil, from 1997 to 1999
Source:
American Society for Microbiology
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Source:
Elsevier BV
Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection
Source:
Taylor & Francis Group
An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
Source:
Springer Nature
Prevalence and phylogenetic analysis of rotavirus genotypes in Thailand between 2007 and 2009.
Source:
Elsevier BV
Absence of Genetic Differences among G10P[11] Rotaviruses Associated with Asymptomatic and Symptomatic Neonatal Infections in Vellore, India
Source:
American Society for Microbiology
Update on global impact and future priorities
Source:
Informa UK Limited
Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa.
Source:
Springer Science and Business Media LLC
Characterization and Molecular Epidemiology of Rotavirus Strains Recovered in Northern Pretoria, South Africa during 2003–2006
Source:
Oxford University Press (OUP)
New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains.
Source:
Elsevier BV
Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus.
Source:
Springer Science and Business Media LLC
Generation of simian rotavirus reassortants with diverse VP4 genes using reverse genetics.
Source:
Microbiology Society
Rotavirus in diarrheal children in rural Burkina Faso: High prevalence of genotype G6P[6]
Source:
Elsevier BV
Antibody Prevalence and Titer to Norovirus (Genogroup II) Correlate with Secretor (FUT2) but Not with ABO Phenotype or Lewis (FUT3) Genotype
Source:
Oxford University Press (OUP)
Recent advancements in combination subunit vaccine development
Source:
Informa UK Limited
Structural basis of glycan specificity of P[19] VP8*: Implications for rotavirus zoonosis and evolution.
Source:
Public Library of Science (PLoS)
Bovine rotavirus pentavalent vaccine development in India
Source:
Elsevier BV
The VP8* Domain of Neonatal Rotavirus Strain G10P[11] Binds to Type II Precursor Glycans
Source:
American Society for Microbiology
Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
Source:
Elsevier BV
Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
Source:
Informa UK Limited
Characterization of G10P[11] Rotaviruses Causing Acute Gastroenteritis in Neonates and Infants in Vellore, India
Source:
American Society for Microbiology
Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium.
Source:
Informa UK Limited
Host Genetic Factors Affect Susceptibility to Norovirus Infections in Burkina Faso
Source:
Avdelningen för mikrobiologi och molekylär medicin
Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production
Source:
American Society for Microbiology
Evaluation of WC3 Rotavirus Vaccine and Correlates of Protection in Healthy Infants
Source:
Oxford University Press (OUP)
Rotavirus Characterization in Vaccinated Infants
Source:
Wiley
Mucin glycan foraging in the human gut microbiome
Source:
Frontiers Media SA
Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity.
Source:
Microbiology Society
Linking provided by
